iShares MSCI China ETF vs Northrop Grumman Corporation — how do they compare? iShares MSCI China ETF trades at $52.43 (market cap $5.94B), while Northrop Grumman Corporation trades at $483.36 (market cap $68.83B). The key difference: Northrop Grumman Corporation is far larger — about 11.6× iShares MSCI China ETF's market cap, and Northrop Grumman Corporation pays a 2.04% dividend while iShares MSCI China ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI China ETF for 63 Days and Northrop Grumman Corporation for 81 Days on average.
| MCHI | NOC | |
|---|---|---|
Market Cap | $5.94B | $68.83B |
Volume | 1,575,471 | 1,081,989 |
Sector | Broad Market / Factor | Industrials |
52-Week High | $65.59 | $768.02 |
52-Week Low | $50.48 | $473.46 |
Typical Hold Time | 63 Days | 81 Days |
Enterprise Value | — | $82.81B |
Dividend Yield | — | 2.04% |
Signals from Pluang's Aura AI — not financial advice
MCHI trades at $52.45, up 1.57% with a bearish technical outlook as moving averages signal strong selling pressure. The ETF faces headwinds from China's economic challenges including industrial overcapacity and weak domestic consumption. Recent news highlights mixed signals with corporate profits surging 26% in Q2 2026 while exports face global pushback. Institutional activity shows conflicting positions with Empowered Funds acquiring shares while Acima Private Wealth reduced holdings.
The outlook remains cautious given China's macroeconomic pressures and trade tensions. Investment opportunity exists in the significant discount to historical valuations, but risks include potential export controls, protectionism threats, and ongoing economic rebalancing challenges that could pressure Chinese equities.
Northrop Grumman (NOC) trades at $479.00, up 1.17% with a bearish technical signal despite strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $7.68 exceeding expectations, supported by a robust $104.7 billion backlog and expanding defense budgets. Recent news highlights both competitive pressures from Boeing's $20B fighter contract win and positive developments in F-35 radar demand.
The investment outlook remains positive with analyst consensus at $600.62 (25% upside) and 54% buy ratings, though technical indicators suggest near-term pressure. Key risks include contract competition and execution challenges on major programs like the B-21 bomber, while strong cash flow generation and dividend growth provide shareholder support.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.
Read more on NOC →